Evaluation of the effect of preprandial ingestion of novel glucomannan containing food on human health.

Evaluation of the effect of preprandial ingestion of novel glucomannan containing food on glucose and lipid metabolism.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs031190087

Enrollment

Registered

2019-09-01

Start date

2019-09-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy subjects or diabetes mellitus controlled under HbA1c 7.0% (NGSP) postprandial hyperglycemia

Interventions

1st time: taking TRELAN G75 225ml 2nd time: after taking G1 fiber or placebo, taking Meas Test S allowing 200ml water

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: healthy subjects or diabetes patients with HbA1c <7%

Exclusion criteria

Exclusion criteria: diabetes patients with HbA1c >= 7% diabetes patients under treatment patients with severe constipation

Design outcomes

Primary

Measure	Time frame
Suppression of the elevation of plasma glucose	—

Secondary

Measure	Time frame
Suppression of the elevation of insulin and elevation of incretin	—

Contacts

Public ContactAkihiro Yoshida

Gunma University Hospital

ayossie10@gunma-u.ac.jp+81-27-220-8576

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026